OTCMKTS:BAYRY - Bayer Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $15.1850 0.00 (-0.03 %) (As of 05/24/2019 04:00 PM ET)Previous Close$15.19Today's Range$15.05 - $15.1952-Week Range$15.05 - $32.80Volume285,169 shsAverage Volume885,949 shsMarket Capitalization$56.64 billionP/E Ratio8.68Dividend Yield3.62%Beta0.95 ProfileAnalyst RatingsChartDividendEarningsFinancialsHeadlinesSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Bayer Aktiengesellschaft operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, Crop Science, and Animal Health segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents. The Consumer Health segment markets nonprescription over-the-counter medicines, medical products, cosmetics, and self-care solutions in the dermatology, nutritional supplements, pain and cardiovascular risk prevention, digestive health, allergy, cold and cough, foot care, and sun protection categories. The Crop Science segment offers chemical and biological crop protection products, improved plant traits, seeds, digital solution, and pest and weed control products, as well as customer service for agriculture. This segment also provides breeding, propagation, and production/processing of seeds, including seed dressing. The Animal Health segment develops and markets products and solutions for the prevention and treatment of disease in companion and farm animals to veterinarians. Bayer Aktiengesellschaft has a collaboration agreement with MD Anderson Cancer Center at the University of Texas to develop cancer treatments; and research collaboration agreements with Haplogen GmbH and Kyoto University to identify new drugs candidates for the treatment of pulmonary diseases. The company distributes its products through wholesalers, pharmacies, supermarket and drugstore chains, online and other retailers, and hospitals, as well as directly to farmers. Bayer Aktiengesellschaft was founded in 1863 and is headquartered in Leverkusen, Germany. Receive BAYRY News and Ratings via Email Sign-up to receive the latest news and ratings for BAYRY and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange OTCMKTS Industry Pharmaceutical preparations Sub-IndustryN/A SectorMedical Current SymbolOTCMKTS:BAYRY Previous Symbol CUSIPN/A CIK1144145 Webhttp://www.bayer.com/ Phone49-21-4-30-1Debt Debt-to-Equity Ratio0.80 Current Ratio1.59 Quick Ratio1.04Price-To-Earnings Trailing P/E Ratio8.68 Forward P/E Ratio7.95 P/E Growth0.78 Sales & Book Value Annual Sales$46.75 billion Price / Sales1.21 Cash Flow$2.5781 per share Price / Cash Flow5.89 Book Value$12.60 per share Price / Book1.21Profitability EPS (Most Recent Fiscal Year)$1.75 Net Income$2.00 billion Net Margins4.74% Return on Equity12.39% Return on Assets4.95%Miscellaneous Employees99,820 Outstanding Shares3,730,000,000Market Cap$56.64 billion Next Earnings Date5/30/2019 (Estimated) OptionableNot Optionable Bayer (OTCMKTS:BAYRY) Frequently Asked Questions What is Bayer's stock symbol? Bayer trades on the OTCMKTS under the ticker symbol "BAYRY." How were Bayer's earnings last quarter? Bayer AG (OTCMKTS:BAYRY) announced its earnings results on Wednesday, February, 27th. The company reported $0.31 earnings per share (EPS) for the quarter, beating the Zacks' consensus estimate of $0.26 by $0.05. The business had revenue of $12.62 billion for the quarter. Bayer had a return on equity of 12.39% and a net margin of 4.74%. View Bayer's Earnings History. When is Bayer's next earnings date? Bayer is scheduled to release their next quarterly earnings announcement on Thursday, May 30th 2019. View Earnings Estimates for Bayer. What is the consensus analysts' recommendation for Bayer? 7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Bayer in the last year. There are currently 1 sell rating, 5 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Bayer. Has Bayer been receiving favorable news coverage? Media headlines about BAYRY stock have trended positive on Saturday, according to InfoTrie Sentiment Analysis. The research group identifies negative and positive news coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Bayer earned a daily sentiment score of 2.3 on InfoTrie's scale. They also assigned media stories about the company a news buzz of 10.0 out of 10, meaning that recent news coverage is extremely likely to have an effect on the company's share price in the immediate future. Who are some of Bayer's key competitors? Some companies that are related to Bayer include Merck & Co., Inc. (MRK), Novartis (NVS), Abbott Laboratories (ABT), AbbVie (ABBV), Novo Nordisk A/S (NVO), Eli Lilly And Co (LLY), Sanofi (SNY), GlaxoSmithKline (GSK), AstraZeneca (AZN), Bristol-Myers Squibb (BMY), Celgene (CELG), Shire (SHPG), Zoetis (ZTS), Allergan (AGN) and Vertex Pharmaceuticals (VRTX). What other stocks do shareholders of Bayer own? Based on aggregate information from My MarketBeat watchlists, some companies that other Bayer investors own include Bank of America (BAC), Pfizer (PFE), Allergan (AGN), General Electric (GE), AT&T (T), Celgene (CELG), CVS Health (CVS), GlaxoSmithKline (GSK), Teva Pharmaceutical Industries (TEVA) and Exxon Mobil (XOM). Who are Bayer's key executives? Bayer's management team includes the folowing people: Mr. Werner Baumann, Chairman of Management & CEO (Age 57)Mr. Wolfgang U. Nickl, CFO & Member of Management Board (Age 50)Mr. Liam Condon, Pres of Bayer Crop Science Division & Member of Management Board (Age 51)Dr. Kemal Malik, Head of Innovation & Member of Management Board (Age 57)Dr. Hartmut Klusik, Head of HR, Technology & Sustainability, Labor Director and Member of Management Board (Age 63) How do I buy shares of Bayer? Shares of BAYRY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is Bayer's stock price today? One share of BAYRY stock can currently be purchased for approximately $15.1850. How big of a company is Bayer? Bayer has a market capitalization of $56.64 billion and generates $46.75 billion in revenue each year. The company earns $2.00 billion in net income (profit) each year or $1.75 on an earnings per share basis. Bayer employs 99,820 workers across the globe. What is Bayer's official website? The official website for Bayer is http://www.bayer.com/. How can I contact Bayer? Bayer's mailing address is Kaiser-Wilhelm-Allee 1, Leverkusen 2M, 51368. The company can be reached via phone at 49-21-4-30-1 or via email at [email protected] MarketBeat Community Rating for Bayer (OTCMKTS BAYRY)Community Ranking: 2.3 out of 5 ( )Outperform Votes: 334 (Vote Outperform)Underperform Votes: 393 (Vote Underperform)Total Votes: 727MarketBeat's community ratings are surveys of what our community members think about Bayer and other stocks. Vote "Outperform" if you believe BAYRY will outperform the S&P 500 over the long term. Vote "Underperform" if you believe BAYRY will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 5/25/2019 by MarketBeat.com StaffFeatured Article: How are dividend achievers different from dividend aristocrats? Receive Analysts' Upgrades and Downgrades Daily Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.